Versant Capital Management, Inc - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2019. The put-call ratio across all filers is 3.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2019$2,000
+100.0%
823
+0.1%
0.00%
Q4 2018$1,000
-50.0%
8220.0%0.00%
-100.0%
Q3 2018$2,000
-84.6%
822
-79.9%
0.00%
-80.0%
Q2 2018$13,000
-23.5%
4,092
-18.7%
0.01%
-28.6%
Q1 2018$17,000
-26.1%
5,036
-6.3%
0.01%
-22.2%
Q4 2017$23,000
+27.8%
5,375
+55.2%
0.01%
-10.0%
Q3 2017$18,0003,4630.01%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders